Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is complement a target for therapy in renal disease?

P W Mathieson1

  • 1Academic Renal Unit, University of Bristol, Bristol, England, United Kingdom. p.mathieson@bris.ac.uk

Kidney International
|December 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function.

Nature communications·2019
Same author

Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells.

Apoptosis : an international journal on programmed cell death·2015
Same author

Insulin directly stimulates VEGF-A production in the glomerular podocyte.

American journal of physiology. Renal physiology·2013
Same author

Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse.

The Journal of pathology·2013
Same author

MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

American journal of physiology. Renal physiology·2012
Same author

High glucose causes dysfunction of the human glomerular endothelial glycocalyx.

American journal of physiology. Renal physiology·2010

The complement system directly causes kidney injury, particularly in glomerulonephritis. New therapies targeting this pathway offer hope for treating renal diseases and preventing transplant rejection.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Complement deposition is common in injured kidneys, especially with glomerulonephritis.
  • The complement system's role in kidney tissue injury is increasingly understood.
  • Local complement production occurs within the kidney.

Purpose of the Study:

  • To review the complement pathway, its regulation, and mechanisms of complement-induced kidney injury.
  • To discuss the renal consequences of complement dysregulation.
  • To examine current and future therapeutic strategies targeting the complement system.

Main Methods:

  • Narrative review of existing literature.
  • Overview of complement pathway and regulatory mechanisms.
  • Analysis of complement's role in renal disease and xenotransplantation.

Related Experiment Videos

Main Results:

  • Complement activation can directly cause kidney tissue injury.
  • The complement system plays a causal role in specific renal diseases.
  • Therapies targeting complement activation are emerging.

Conclusions:

  • The complement system is a direct cause of injury in certain kidney diseases.
  • Specific therapies can interrupt complement activation or promote regulation.
  • Complement inhibitors developed for xenotransplantation hold promise for primary renal diseases.